Stanley Plotkin, MD

Consultant and Emeritus Professor, University of Pennsylvania, Vaxconsult, LLP

Paul Offit, MD

Director, Vaccine Education Center, Division of Infectious Diseases, Children's Hospital of Philadelphia.

William C. Gruber, MD

SVP Vaccine Clinical Research and Development, Pfizer Inc

John Howard, MS, MBA

President and Founder, Applied Biotechnology Institute, Inc (ABI)

Drew Weissman, MD, PhD

Professor, Department of Medicine, Director of Vaccine Research, Infectious Diseases Division, Perelman School of Medicine, University of Pennsylvania

Kayvon Modjarrad, M.D., Ph.D

Director, Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research

Ruxandra Draghia-Akli, MD, Ph.D

Global Head, Global Public Health R&D, Johnson & Johnson

Jay A. Berzofsky, M.D., Ph.D.

Chief, Vaccine Branch,
Center for Cancer Research,
National Cancer Institute

Alba Grifoni PhD

La Jolla Institute for Immunology

Adrian V.S. Hill MD, Ph.D.

Director, The Jenner Institute, Nuffield Department of Medicine, University of Oxford

Raches Ella, MBBS, MS

Head - Business Development & Advocacy, Bharat Biotech

Nikolai Petrovsky, MBBS, Ph.D

Flinders University, Australia, Research Director, Vaxine Pty Ltd

Karen A. Norris, Ph.D.

Professor, Georgia Research Alliance Eminent Scholar, Charles H. Wheatley Chair in Immunology and Translational Biomedical Research, Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia

Ralph S. Baric, Ph.D.

University of North Carolina Kenan Distinguished Professor, Epidemiology, Gillings School of Global Public Health and Microbiology and Immunology, School of Medicine.

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, FDA

Mark J. Newman, Ph.D.

Chief Scientific Officer, GeoVax Inc

Alexander Bukreyev, Ph.D.

Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, University of Texas Medical Branch

Kenneth D. Stuart, Ph.D.

Professor, University of Washington School of Medicine, Department of Pediatrics and Seattle Children’s Research Institute, Center for Global Infectious Disease Research (CGIDR)

James E. Crowe, Jr., M.D.

Director, Vanderbilt Vaccine Center

Daniela Weiskopf, M.D., Ph.D

Research Assistant Professor, La Jolla Institute for Immunology

Kwong Tsang, Ph.D

CSO, Precision Biologics, Inc

Michael Schotsaert, Ph.D

Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Joseph A. Vetro, Ph.D.

Associate Professor, Department of Pharmaceutical Sciences, University of Nebraska Medical Center

Leonidas Stamatatos, Ph.D.

Professor, Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division

Stephen Albert Johnston, Ph.D

Co-Founder, Calviri, Inc

Barbara A. Jones, Ph.D

IBM Research Almaden

Denise L Faustman, M.D., Ph.D.

Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Wei Shen, Ph.D.

Immunomic Therapeutics, Inc.

Peter Palese, PhD

Horace W. Goldsmith Professor and Chair, Department of Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai

Seshadri S. Vasan, DPhil(Oxon)

Honorary Professor of Health Sciences, University of York, UK

Thomas Tillett, PhD

CEO, MBF Therapeutics

Li Shi, PhD

Yidao Biotechnology CO., Ltd

Tomas Hanke, PhD

The Jenner Institute, Nuffield Department of Medicine, University of Oxford

M. Javad Aman, PhD

President and CSO, Integrated Biotherapeutics Inc.,

Paul LaBarre, MS, MBA

Vice President of Global Business Development, PharmaJet

Stéphane Pillet, PhD

Clinical Immunology Manager, Scientific and Medical Affairs, Medicago

Raiees Andrabi, PhD

Institute Investigator, Department of Immunology and Microbiology, The Scripps Research Institute

Philip R Krause

Former FDA Deputy Director, Office of Vaccines Research and Review, Consultant, World Health Organization

Andrew M. Lewis JR., MD

Office of Vaccines Research and Review, Division of Viral Products, Laboratory of DNA Viruses

Pravin T.P. Kaumaya, PhD

Professor Ob/Gyn, Molecular and Cellular Biochemistry, Director Div. of VACCINE DEVELOPMENT/ Peptide & Protein Engineering Laboratory

Steve Steinhubl, MD

Chief Medical Officer, physIQ

Yang Xu, PhD

Director and full professor, Shanghai University of Medicine and Health Sciences

Shelly J. Krebs, PhD

Chief, B cell Biology I HJF, In support of the US Military HIV Research Program (MHRP), and the Emerging Infectious Disease Branch (EIDB), Walter Reed Army Institute of Research (WRAIR)

Theodore (Ted) Schenkelberg, MBA, MPH

Senior Vice President and Chief Strategy Officer, Human Vaccines Project

Jonathan Lovell, PhD

Associate Professor of Biomedical Engineering, University at Buffalo

Marco Pravetoni, PhD

Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine; Director, Center for Medication Development for Substance Use Disorders and Overdose

Catarina Hioe, PhD

Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai

Savannah Knell

Senior Director of Strategic Partnerships, The Public Good Projects (PGP)

Joe Smyser, PhD

CEO, PGP (The Public Good Projects)

David C. Montefiori, PhD

Professor, Department of Surgery, Director, Laboratory for HIV and COVID-19 Vaccine Research & Development, Department of Surgery, Duke University Medical Center

Nash Rochman

IRTA Fellow, National Institute of Health

Rama Rao Amara, PhD

Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Yerkes National Primate Research Center, Emory University

Lisa M. Dunkle, MD

Vice President, Clinical Development, Global Medical Lead, Coronavirus Vaccine, Novavax, Inc.

David J. Dowling, PhD

Principal Investigator, Adjuvant Discovery and Development Lab, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, & Instructor of Pediatrics, Harvard Medical School. Harvard Institutes of Medicine

Samuel Fosu Gyasi, PhD

Associate Professor: Microbiology and Global Health, Head; Centre for Research in Applied Biology (CeRAB), University of Energy & Natural Resources-Ghana

Leonora Hana Lleshi, MD

Allergist-immunologist, KOSOVO

Waranyoo Phoolcharoen

Associate Professor, Faculty of Pharmaceutical Sciences, Chulalongkorn University, CTO and Co-Founder, Baiya Phytopharm Co., Ltd

SIDDAPPA N. BYRAREDDY, PhD

Professor & Vice Chair of Research, Department of Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center

Patrick Ahl, PhD

Principal Scientist, Merck Vaccine R&D

Sidi Chen

Yale School of Medicine

Nektaria Karavas

Director of Business Development, Prescription Division, Aptar Pharma

Julie D. Suman, RPh, PhD

Vice President of Scientific Affairs, Aptar Pharma

Maria Gomes-Solecki, RPh, PhD

Professor of Microbiology, Immunology and Biochemistry at the University of Tennessee Health Science Center

Phanramphoei (Jibby) Frantz

National Center for Genetic Engineering and Biotechnology (BIOTEC) & Institut Pasteur